Feb 6, 2018
Cancer is still one of the main causes of death worldwide, yet recent strides towards more effective treatments have been made in the form of new cancer immunotherapies. By weaponising the body’s own immune defences, these drugs have shown great promise in clinical trials and are now experiencing significant commercial success.
In this episode, we discuss: active immunotherapies, passive immunotherapies, using biomarkers to monitor the immune sytem, and a new autoantibody profiling tool for cancer immunotherapies
The original article this episode is based on was written by Dr Peter Schulz-Knappe and Dr Georg Lautscham. If you'd like to view the original article then follow the link below:
You can also download the original article pdf here:
For more information on Drug Discovery World, head to: